Technetium (99mTc) votumumab

From WikiMD's Food, Medicine & Wellness Encyclopedia



Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1] It was developed for the detection of colorectal tumors, but has never been marketed.[2]

The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[3]

References[edit | edit source]

  1. ↑ WHO Drug Information
  2. ↑ EMA: Public Statement on HumaSPECT Archived 2007-06-10 at the Wayback Machine
  3. ↑ EMA: Summary of Product Characteristics for HumaSPECT



Stub icon

This monoclonal antibody–related article is a stub. You can help WikiMD by expanding it.

‎

Technetium (99mTc) votumumab Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Retrieved from "https://wikimd.com/w/index.php?title=Technetium_(99mTc)_votumumab&oldid=5210453"

Contributors: Prab R. Tumpati, MD